Changes in elastin degradation immunological indices in patients with moderate arterial hypertension maintained on systematic antihypertension treatment

Biotechnology and Biotechnological Equipment

Volumn 19, Issue 3, 2005, Pages 149-159

  Tisheva, S ^a  

^a Cardiology Clinic Professor Kiril Chichovski   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26844483807     PISSN: 13102818     EISSN: None     Source Type: Journal    
DOI: 10.1080/13102818.2005.10817244     Document Type: Article

References (18)

1. Bajdanov S., Nikolov G., (1985) Izsledvane Organnata Specifichnost na Choveshki Elastin chrez enzymsvarzana immunosorbentna proba (ELISA), Sbornik na VMI Pleven (on Bulgarian).
2. Nikolov G., (1988) PhD Thesis:Prouchvane na niakoi immunologichni aspecti na elastinovata obmijana, Pleven (on Bulgarian).
3. Asmar R.G., London G.M., O'Rourke M.F., Safar M.E., (2001) Hypertension, 3, 922–926.
4. Asmar R., (1999) Arterial Stiffness and Pulse Wave Velocity., Clinical Applications., Édition scientifiquees et medicales Elsevier SAS.
5. Baydanoff S., Nikolov G., Alexiev Ch., (1986b) Compt. Rend. Acad. Bulg. Sci., 39(7) 131–133.
6. Baydanoff S., Nikolov G., Gancheva Z., Cherov A., Kozhouharova M., (1986a) Compt. Rend. Acad. Bulg. Sci., 39(6) 89–91.
7. Baydanoff S., Nikolov G., (1986b) Compt. Rend. Acad. Bulg. Sci., 39(6) 85–88.
8. Benetos A., Bouaziz H., Albaladejo P., Levy B.I., Safar M.E., (1992) J. Hypertens, 10(6) S127–131.
9. Benetos A., Santoni J.P., Safar M.E., (1990) J. Hypertens, 8, 819–826.
10. Damiano V.V., Tsang A., Kucich U., Veinbaum G., Rosenbloom J., (1981) Conn. Tiss. Res., 8, 185–188.
11. Dzau V.J., Horiuchi M., (1998) Vascular re-modeling--the emerging paradigm of programmed cell death (apoptosis):the Francis B. Parker Lectureship, Chest, 114(1 Suppl), 91S–99S.
12. Jeffrey M.D., Giro M.G., (1996) Circ. Res., 76, 1103–1109.
13. Heagerty A.M., Aalkjaer C., Bund S.J., et al. (1993) Hypertension, 21(4) 391–397.
14. Nicoloff G., Badanoff S., Perova Ch., Christova P., (2002) Antibodies to advanced glycation end products in Children with diabetes mellitus., General Pharmacology.
15. Nicoloff G., Baydanoff S., Stanimirova N., Petrova Ch., (2000) General Pharmacology, 35(2) 83–87.
16. O'Rourke M., (1995) Hypertension, 26, 2–9.
17. Schiffrin E.L., (2002) Am. J. Hypertens, 15(10 Pt 2), 115S–122S.
18. Shinohara T., Suzuki K., Okada M., Shiigai M., Shimizu M., Maehara T., Ohsuzu F., (2003) Arterioscler Thromb. Vasc. Biol., 23(10) 1839–1844.